• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西胸科协会间质性肺疾病指南要点。

Highlights of the Brazilian Thoracic Association guidelines for interstitial lung diseases.

机构信息

Instituto do Coração Divisão de Pneumologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

J Bras Pneumol. 2012 May-Jun;38(3):282-91. doi: 10.1590/s1806-37132012000300002.

DOI:10.1590/s1806-37132012000300002
PMID:22782597
Abstract

Interstitial lung diseases (ILDs) are heterogeneous disorders, involving a large number of conditions, the approach to which continues to pose an enormous challenge for pulmonologists. The 2012 Brazilian Thoracic Association ILD Guidelines were established in order to provide Brazilian pulmonologists with an instrument that can facilitate the management of patients with ILDs, standardizing the criteria used for the diagnosis of different conditions and offering guidance on the best treatment in various situations. The objective of this article was to briefly describe the highlights of those guidelines.

摘要

间质性肺疾病(ILDs)是异质性疾病,涉及大量病症,其治疗方法仍然对肺病学家构成巨大挑战。2012 年巴西胸科协会ILD 指南的制定旨在为巴西肺病学家提供一种工具,以方便ILDs 患者的管理,标准化不同病症的诊断标准,并为各种情况下的最佳治疗提供指导。本文的目的是简要描述这些指南的要点。

相似文献

1
Highlights of the Brazilian Thoracic Association guidelines for interstitial lung diseases.巴西胸科协会间质性肺疾病指南要点。
J Bras Pneumol. 2012 May-Jun;38(3):282-91. doi: 10.1590/s1806-37132012000300002.
2
Update on the diagnosis and classification of ILD.特发性肺纤维化诊断和分类的更新。
Curr Opin Pulm Med. 2013 Sep;19(5):453-9. doi: 10.1097/MCP.0b013e328363f48d.
3
Chronic interstitial lung diseases in children.儿童慢性间质性肺疾病。
J Bras Pneumol. 2009 Aug;35(8):792-803. doi: 10.1590/s1806-37132009000800012.
4
Interstitial lung diseases: an epidemiological overview.间质性肺疾病:流行病学概述
Eur Respir J Suppl. 2001 Sep;32:2s-16s.
5
A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.一项针对丹麦间质性肺疾病患者的队列研究:负担、严重程度、治疗与生存情况。
Dan Med J. 2015 Apr;62(4):B5069.
6
Interstitial lung diseases: clinical features and management.间质性肺疾病:临床特征与管理
Nurs Times. 2005;101(25):58-61.
7
The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.间质性肺疾病多学科会议:澳大利亚和新西兰胸科学会及澳大利亚肺脏基金会的立场声明。
Respirology. 2017 Oct;22(7):1459-1472. doi: 10.1111/resp.13163. Epub 2017 Sep 10.
8
Interstitial lung diseases in the hospitalized patient.住院患者的间质性肺疾病
BMC Med. 2015 Sep 25;13:245. doi: 10.1186/s12916-015-0487-0.
9
Unclassifiable interstitial lung disease: A review.不可分类的间质性肺疾病:综述
Respirology. 2016 Jan;21(1):51-6. doi: 10.1111/resp.12568. Epub 2015 Jun 9.
10
Interstitial lung diseases: an observational study in patients admitted in "Marius Nasta" Institute of Pulmonology Bucharest, Romania, in 2011.间质性肺疾病:2011年在罗马尼亚布加勒斯特“马里乌斯·纳斯塔”肺病研究所收治患者的一项观察性研究。
Pneumologia. 2013 Oct-Dec;62(4):206-11.

引用本文的文献

1
Clinical Characteristics of Individuals with Interstitial Lung Diseases and Indication of End-of-Life Care.间质性肺疾病患者的临床特征及临终关怀指征
J Clin Med. 2023 Nov 25;12(23):7314. doi: 10.3390/jcm12237314.
2
Translation, cross-cultural adaptation, and measurement properties of the Brazilian-Portuguese version of the idiopathic pulmonary fibrosis-specific version of the Saint George's Respiratory Questionnaire (SGRQ-I) for patients with interstitial lung disease.特发性肺纤维化圣乔治呼吸问卷(SGRQ-I)巴西葡萄牙语版本的翻译、跨文化适应性和测量特性,用于间质性肺疾病患者。
Braz J Phys Ther. 2021 Nov-Dec;25(6):794-802. doi: 10.1016/j.bjpt.2021.06.008. Epub 2021 Jul 21.
3
Carbohydrate antigen 15-3 as a marker of disease severity in patients with chronic hypersensitivity pneumonitis.
碳水化合物抗原 15-3 作为慢性变应性肺炎患者疾病严重程度的标志物。
J Bras Pneumol. 2021 Mar 8;47(1):e20200589. doi: 10.36416/1806-3756/e20200589. eCollection 2021.
4
Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology.巴西特发性肺纤维化药物治疗指南。基于 GRADE 方法学的巴西胸科协会官方文件。
J Bras Pneumol. 2020 Mar 2;46(2):e20190423. doi: 10.36416/1806-3756/e20190423. eCollection 2020.
5
Translation and cultural adaptation of the King's Brief Interstitial Lung Disease health status questionnaire for use in Brazil.巴西版 King's 简短间质性肺病健康状况调查问卷的翻译与文化调适。
J Bras Pneumol. 2019 Sep 16;45(5):e20180194. doi: 10.1590/1806-3713/e20180194.
6
Characterization and outcomes of pulmonary alveolar proteinosis in Brazil: a case series.巴西肺泡蛋白沉积症的特征和结局:病例系列研究。
J Bras Pneumol. 2018 May-Jun;44(3):231-236. doi: 10.1590/S1806-37562017000000168.
7
Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.淋巴管平滑肌瘤病中的肺动脉高压:患病率、严重程度及一氧化碳弥散能力作为一种筛查方法的作用
Orphanet J Rare Dis. 2017 Apr 20;12(1):74. doi: 10.1186/s13023-017-0626-0.
8
Respiratory muscles in interstitial lung disease: poorly explored and poorly understood.间质性肺疾病中的呼吸肌:研究不足且了解甚少。
J Bras Pneumol. 2016 Apr;42(2):82-3. doi: 10.1590/S1806-37562016000200002.
9
How many patients with idiopathic pulmonary fibrosis are there in Brazil?巴西有多少特发性肺纤维化患者?
J Bras Pneumol. 2015 Nov-Dec;41(6):560-1. doi: 10.1590/S1806-37562015000000165.
10
Update on diagnosis and treatment of idiopathic pulmonary fibrosis.特发性肺纤维化的诊断与治疗进展
J Bras Pneumol. 2015 Sep-Oct;41(5):454-66. doi: 10.1590/S1806-37132015000000152.